ABSTRACT
Central serous chorioretinopathy is a common cause of visual morbidity.It is characterized by idiopathic serous retinal detachment in macular orparamacular regions. The symptoms of the CSC include decreased vision,micropsia and metamorphopsia. The prognosis of the disease is good andalmost 90% of patients obtain visual recovery in a few months. However,in less than 5% of patients the chronic disease with poor prognosis isdeveloped.The acceptable approach is to observe patients with acute central serouschorioretinopathy, because central serous chorioretinopathy is selflimited.The pathophysiology of central serous chorioretinopathy is notclear and not well understood. Therefore, various medical treatmentshave been suggested such as propranolol, indomethacin, bevacizumab,acetazolamide, mifepristone, labetalol, etc. However, wait and watchwould be the most recommended management of the central serouschorioretinopathy